403MO Atezolizumab in combination with bevacizumab for patients with unresectable/metastatic anal cancer
Van K. Morris, S. Liu, Benny Johnson, C. Shambu Prasad, Armeen Mahvash, Priya Bhosale, Michael Rubin, Nicole D. Rothschild, P. Andrew Futreal, Ignacio I. Wistuba, Patrick Hwu, James C. Yao, Cathy Eng, Daniel M. Halperin
Topics & Concepts
MedicineAtezolizumabBevacizumabInternal medicineResponse Evaluation Criteria in Solid TumorsOncologyGastroenterologyProgressive diseaseCancerImmunotherapyNivolumabChemotherapyColorectal and Anal CarcinomasCancer Immunotherapy and BiomarkersCervical Cancer and HPV Research